Literature DB >> 21831563

How is tobacco treatment provided during drug treatment?

Jamie J Hunt1, A Paula Cupertino, Susan Garrett, Peter D Friedmann, Kimber P Richter.   

Abstract

The purpose of this study was to obtain descriptions of tobacco treatment services across different substance abuse treatment settings. We conducted mixed-method assessments in eight facilities among eight directors, 25 staff, 29 clients, and 82 client charts. Measures included systems assessment, chart reviews, and semistructured interviews. Although many programs reported they offer key components of evidence-based treatment, few actually provided any treatment and none did so systematically. Many addressed tobacco as part of drug education or part of a health promotion session. Chart reviews suggested that provision of tobacco treatment is rare. By many reports, clients had to specifically request treatment and few staff reported encouraging unmotivated smokers to quit. Systems to facilitate consistent, evidence-based tobacco treatment and to implement quality improvement were nonexistent. The findings imply that drug treatment facilities may need to build capacity in several domains to deliver care that is consistent with national guidelines.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21831563      PMCID: PMC3223282          DOI: 10.1016/j.jsat.2011.06.007

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  32 in total

Review 1.  Smoking cessation treatment for substance misusers in early recovery: a review of the literature and recommendations for practice.

Authors:  D Kalman
Journal:  Subst Use Misuse       Date:  1998-08       Impact factor: 2.164

2.  Interest in smoking cessation among methadone maintained outpatients.

Authors:  D L Frosch; S Shoptaw; M E Jarvik; R A Rawson; W Ling
Journal:  J Addict Dis       Date:  1998

3.  Smoking habits and attitudes in a methadone maintenance treatment population.

Authors:  P Clemmey; R Brooner; M A Chutuape; M Kidorf; M Stitzer
Journal:  Drug Alcohol Depend       Date:  1997-03-14       Impact factor: 4.492

4.  Distribution of smokers by stage in three representative samples.

Authors:  W F Velicer; J L Fava; J O Prochaska; D B Abrams; K M Emmons; J P Pierce
Journal:  Prev Med       Date:  1995-07       Impact factor: 4.018

5.  Treatment of smoking cessation in smokers with past alcohol/drug problems.

Authors:  J R Hughes
Journal:  J Subst Abuse Treat       Date:  1993 Mar-Apr

6.  A 24-year follow-up of California narcotics addicts.

Authors:  Y I Hser; D Anglin; K Powers
Journal:  Arch Gen Psychiatry       Date:  1993-07

7.  Smoking cessation services in U.S. methadone maintenance facilities.

Authors:  Kimber P Richter; Won S Choi; Robert M McCool; Kari J Harris; Jasjit S Ahluwalia
Journal:  Psychiatr Serv       Date:  2004-11       Impact factor: 3.084

8.  Alcoholism and smoking.

Authors:  J R DiFranza; M P Guerrera
Journal:  J Stud Alcohol       Date:  1990-03

9.  Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort.

Authors:  R D Hurt; K P Offord; I T Croghan; L Gomez-Dahl; T E Kottke; R M Morse; L J Melton
Journal:  JAMA       Date:  1996-04-10       Impact factor: 56.272

10.  Mortality in relation to smoking: 50 years' observations on male British doctors.

Authors:  Richard Doll; Richard Peto; Jillian Boreham; Isabelle Sutherland
Journal:  BMJ       Date:  2004-06-22
View more
  14 in total

1.  Barriers to Telephone Quitline Use Among Methadone-Maintained Smokers.

Authors:  Judith L Griffin; Kate S Segal; Shadi Nahvi
Journal:  Nicotine Tob Res       Date:  2015-08       Impact factor: 4.244

2.  Concurrent alcohol and tobacco treatment: Effect on daily process measures of alcohol relapse risk.

Authors:  Ned L Cooney; Mark D Litt; Kevin A Sevarino; Lucienne Levy; Linda S Kranitz; Helen Sackler; Judith L Cooney
Journal:  J Consult Clin Psychol       Date:  2015-01-26

3.  Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial.

Authors:  Shadi Nahvi; Yuming Ning; Kate S Segal; Kimber P Richter; Julia H Arnsten
Journal:  Addiction       Date:  2014-06-27       Impact factor: 6.526

4.  Tobacco smoking interferes with GABAA receptor neuroadaptations during prolonged alcohol withdrawal.

Authors:  Kelly P Cosgrove; Reese McKay; Irina Esterlis; Tracy Kloczynski; Evgenia Perkins; Frederic Bois; Brian Pittman; Jack Lancaster; David C Glahn; Stephanie O'Malley; Richard E Carson; John H Krystal
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

5.  Organizational factors as predictors of tobacco cessation pharmacotherapy adoption in addiction treatment programs.

Authors:  Jessica L Muilenburg; Tanja C Laschober; Lillian T Eby
Journal:  J Addict Med       Date:  2014 Jan-Feb       Impact factor: 3.702

6.  Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness.

Authors:  Shadi Nahvi; Bryan Wu; Kimber P Richter; Steven L Bernstein; Julia H Arnsten
Journal:  Drug Alcohol Depend       Date:  2013-01-17       Impact factor: 4.492

7.  Perceived implementation of the Office of Alcoholism and Substance Abuse Services (OASAS) tobacco-free regulation in NY State and clinical practice behaviors to support tobacco cessation: a repeated cross-sectional study.

Authors:  Lillian T de Tormes Eby; Tanja C Laschober
Journal:  J Subst Abuse Treat       Date:  2013-01-30

8.  Behavioral Healthcare Staff Attitudes and Practices Regarding Consumer Tobacco Cessation Services.

Authors:  J Randy Koch; Alison Breland
Journal:  J Behav Health Serv Res       Date:  2017-07       Impact factor: 1.505

9.  Medicaid, Private Insurance, and the Availability of Smoking Cessation Interventions in Substance Use Disorder Treatment.

Authors:  Hannah K Knudsen; Paul M Roman
Journal:  Psychiatr Serv       Date:  2015-08-03       Impact factor: 3.084

10.  Use of Smoking Cessation Methods Among Patients Receiving Office-based Buprenorphine Maintenance Treatment.

Authors:  Pooja A Shah; Chinazo O Cunningham; Mia T Brisbane; Joseph P DeLuca; Shadi Nahvi
Journal:  J Addict Med       Date:  2017 Nov/Dec       Impact factor: 3.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.